Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 115 pages
Exam (elaborations)

NAMS MENOPAUSE CERTIFICATION EXAM 400 ACTUAL QUESTIONS AND CORRECT ANSWERS WITH RATIONALE ALREADY GRADED A+ LATEST UPDATE

Document preview thumbnail
Preview 4 out of 115 pages

Are you a healthcare professional preparing for the NAMS (The Menopause Society) Certified Practitioner (NCMP/MSCP) exam? This comprehensive question bank is your ultimate study companion for mastering the essential knowledge required to pass the exam and excel in menopause medicine. Designed to mirror the content, difficulty, and clinical application of the actual NAMS certification exam, this resource will help you build confidence, identify knowledge gaps, and achieve certification success. What's Inside: This extensive resource provides 400 high-yield, multiple-choice questions covering the full spectrum of menopause medicine topics. But more than just questions, you get: Correct Answers & Detailed Evidence-Based Rationales: Every single question is paired with the correct answer and a clear, detailed rationale. These rationales explain why the answer is correct and why the distractors are incorrect, reinforcing key pathophysiological concepts, clinical reasoning, and guideline-supported management. This transforms each question into a powerful learning opportunity. Comprehensive Content Coverage: The questions are meticulously organized to cover all essential NAMS exam domains, including: STRAW+10 Staging System: Reproductive aging stages, early and late menopausal transition, early and late postmenopause. Hormonal Physiology & Pharmacokinetics: Estrogen, progesterone, FSH, LH, AMH, inhibin B, and the climacteric phase. Hormone Therapy (HT): Estrogen and progestogen formulations, routes of administration, dosing, contraindications, risks (VTE, stroke, breast cancer, CHD), and benefits (bone health, symptom relief). Genitourinary Syndrome of Menopause (GSM): Vaginal atrophy, dyspareunia, urinary symptoms, treatment options (vaginal estrogen, moisturizers, lubricants, ospemifene). Vulvar Dermatologic Conditions: Lichen sclerosus, lichen planus, vulvodynia, desquamative inflammatory vaginitis (DIV), and vulvar intraepithelial neoplasia (VIN). Cardiovascular & Metabolic Effects: CHD risk, stroke, lipid effects, glucose metabolism, and obesity. Breast & Endometrial Cancer Risk: HT and breast cancer, endometrial hyperplasia, atypical hyperplasia, and surveillance. Venous Thromboembolism (VTE): Risk factors, oral vs. transdermal estrogen, and management. Non-Hormonal Therapeutic Alternatives: SSRIs/SNRIs, gabapentin, fezolinetant, and cognitive behavioral therapy. Special Populations: POI, breast cancer survivors, endometriosis, migraines, thrombophilia, and liver disease. Why This Resource is Essential: Pass Your NAMS Exam: This question bank is specifically designed to help you pass the NAMS Menopause Certification exam on your first attempt. Reinforce Clinical Knowledge: The detailed rationales help you integrate pathophysiology, clinical presentation, and evidence-based management for menopausal patients. Identify Your Weak Areas: By working through these questions, you can quickly identify your areas of weakness and focus your study time more effectively. Study Anywhere: Use this resource on your computer, tablet, or phone for convenient, flexible study sessions. Exam-Style Preparation: The questions are formatted to match the style and difficulty of the actual NAMS exam, ensuring you are fully prepared for test day. This comprehensive question bank is an indispensable tool for anyone serious about earning their NAMS Menopause Certification and advancing their career in women's health. Order today and take a major step toward professional certification!

Content preview

NAMS MENOPAUSE CERTIFICATION EXAM 400 ACTUAL
QUESTIONS AND CORRECT ANSWERS WITH RATIONALE
ALREADY GRADED A+ LATEST UPDATE



This comprehensive question bank provides 400 multiple-choice questions
designed specifically for the NAMS (Menopause Society) Certified
Practitioner (NCMP/MSCP) examination. The content systematically covers
the core domains of menopause medicine, including the STRAW+10 staging
system, hormonal physiology, pharmacokinetics of hormone therapy,
contraindications and risk management, genitourinary syndrome of
menopause (GSM), vulvar dermatologic conditions, cardiovascular and
metabolic effects, breast and endometrial cancer risks, venous
thromboembolism, migraine and neurologic considerations, bone health, and
non-hormonal therapeutic alternatives. Each question is structured with a
clinical vignette, four answer options, a single correct answer, and a detailed
evidence-based rationale that explains the pathophysiology, clinical reasoning,
and guideline-supported management. This resource serves as a rigorous self-
assessment tool for clinicians preparing for board certification, reinforcing
both foundational knowledge and practical clinical decision-making in
menopausal care.



1. What is the “climacteric phase”?
A) The final menstrual period
B) The period of endocrinologic, somatic, and transitory psychologic changes
around the time of menopause
C) The perimenopause only
D) The postmenopausal period
Correct Answer: B
Rationale: The climacteric phase is the period of endocrinologic, somatic, and
transitory psychologic changes that occur around the time of menopause. It
encompasses the transition from the reproductive stage to the non-reproductive
stage .

2. What is the definition of “early menopause”?

, A) LMP before age 40
B) LMP before age 45
C) LMP before age 50
D) LMP after age 55
Correct Answer: B
Rationale: Early menopause is defined as the last menstrual period (LMP)
occurring before age 45. It should be distinguished from primary ovarian
insufficiency, which occurs before age 40 .

3. What is the definition of “late menopause”?
A) LMP after age 50
B) LMP after age 54
C) LMP after age 55
D) LMP after age 60
Correct Answer: B
Rationale: Late menopause is defined as an LMP after age 54 .

4. What term describes menopause that occurs before age 40?
A) Early menopause
B) Premature ovarian insufficiency (POI)
C) Late menopause
D) Premenopause
Correct Answer: B
Rationale: Primary ovarian insufficiency (POI) is defined as the loss of ovarian
function before the age of 40. It is distinguished from early menopause, which
occurs between ages 40 and 45 .

5. According to the STRAW+10 staging system, what characterizes “early
menopause transition” (stage –2)?
A) 60 or more consecutive days of amenorrhea
B) Persistent difference of 7 days or more in the length of consecutive cycles
C) Heavy menstrual bleeding
D) Regular cycles 26–35 days
Correct Answer: B
Rationale: Stage –2 (early menopause transition) is marked by persistent
difference of ≥ 7 days in the length of consecutive cycles and is when cycle
irregularity begins .

6. What does the luteal out-of-phase (LOOP) event explain?
A) Elevated FSH in early menopause

, B) Elevated estrogen levels in perimenopausal women
C) Low progesterone in perimenopause
D) Androgen excess in menopause
Correct Answer: B
Rationale: The LOOP event explains why some perimenopausal women have
elevated estrogen levels occasionally. Elevated FSH recruits a second follicle,
causing a follicular-phase-like rise in estradiol superimposed on the mid-to-late
luteal phase of the ovulatory cycle .

7. In which post-menopausal stage do vasomotor symptoms (VMS) predominate?
A) Stage +1a, +1b, +1c (early postmenopause)
B) Stage +2 (late postmenopause)
C) Menopause transition
D) Late reproductive years
Correct Answer: A
Rationale: In early postmenopause (stage +1a, +1b, +1c), which is the first 2
years after the final menstrual period (FMP), FSH rises, estradiol decreases, and
VMS predominate. Later stages are dominated by urogenital and somatic aging .

8. What are the typical endocrine laboratory findings after menopause?
A) Low FSH, low LH, high estradiol
B) Elevated FSH and LH, low estradiol
C) Low FSH, high LH, high progesterone
D) Normal FSH, low estradiol
Correct Answer: B
Rationale: After menopause, the ovaries no longer produce significant estrogen,
leading to loss of negative feedback and elevated FSH and LH. Low estradiol is the
expected finding .

9. Which laboratory marker is considered a superior marker of menopause?
A) FSH
B) LH
C) AMH (anti-Müllerian hormone)
D) Inhibin B
Correct Answer: C
Rationale: AMH (anti-Müllerian hormone) is a superior marker for menopause.
It is produced by the ovarian follicle pool and declines as follicles are depleted,
making it a better reflection of ovarian reserve. FSH can be variable in
perimenopause .

, 10. Where are estrogen receptors located? (Select all that apply)
A) Vagina
B) Vulva
C) Urethra
D) Trigone of the bladder
Correct Answer: A, B, C, D
Rationale: Estrogen receptors are abundant throughout the lower urinary and
genital tracts, including the vagina, vulva, urethra, and trigone of the bladder. This
explains why estrogen therapy is effective for genitourinary syndrome of
menopause (GSM) .

11. What are the vaginal changes associated with menopause?
A) Thickening of the vaginal epithelium
B) Thinning, loss of elasticity, and loss or absence of rugae
C) Increased rugae and increased elasticity
D) No change
Correct Answer: B
Rationale: Menopause leads to thinning of the vaginal epithelium, loss of
elasticity, and loss or absence of rugae due to estrogen deficiency. These changes
contribute to GSM symptoms such as dyspareunia, dryness, and irritation .

12. How does menopause alter the anatomy of the vagina and urethra?
A) The vagina widens, and the urethra moves away from the introitus
B) The vagina narrows, and the urethra moves closer to the introitus
C) The vagina lengthens, and the urethra shortens
D) No anatomic changes occur
Correct Answer: B
Rationale: Estrogen deficiency during menopause causes narrowing of the
vagina and a shortening of the urethra, which can move closer to the introitus.
These changes increase the risk of stress urinary incontinence and recurrent urinary
tract infections .

13. Compared with white, black, and Hispanic women, Chinese and Japanese
women tend to have:
A) Higher estradiol levels
B) Similar estradiol levels
C) Lower estradiol levels
D) Variable levels with no pattern
Correct Answer: C

Document information

Uploaded on
June 22, 2026
Number of pages
115
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$20.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
PrepPulse
3.3
(3)
Sold
26
Followers
0
Items
1414
Last sold
1 day ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions